Skip to main content
. 2018 May 22;8(2):320–328. doi: 10.1016/j.ijpddr.2018.05.003

Table 3.

Prevalence of major haplotypes of known drug resistance genes in parasites from different years.

Gene H Haplotypea 2007 (n = 21) 2008 (n = 41) 2009 (n = 22) 2010 (n = 10) 2012 (n = 13) Total (n = 107)
Pfcrt
1
CIETS
100
100
100
100
100
100
Pfmdr1
5
NYN 66.7 56.1 54.5 90.0 92.3 65.4
NFN
23.8
43.9
31.8
10.0
7.7
29.9
Pfdhfr
4
IRNI 19.0 12.2 22.7 20.0 23.1 17.8
NRNL 28.6 31.7 36.4 30.0 7.7 29.0
IRNL
42.9
53.7
40.9
50.0
53.8
48.6
Pfdhps
12
SGEA 9.5 7.3 20.0 6.5
AGEA 47.6 31.7 45.5 40.0 23.1 37.4
SGEG 19 31.7 22.7 30.0 38.5 28.0
AGEG

9.8
9.1


5.6
Pfmrp1
22
HNSHITF 28.6 17.1 22.7 50.0 15.4 23.4
YNAHVTF 33.3 24.4 18.2 19.6
YSAHITF 9.8 4.5 7.7 5.6
YNAHVTI 4.8 12.2 9.1 7.7 8.4
YNAHVMF 4.8 9.8 27.3 10.0 11.2
YNANVMF
4.8
9.8

10.0
30.8
9.3
Pfnhe1 11 MS-1 (2) 14.3 9.8 9.1 10.0 7.7 10.3
MS-5 (4) 4.9 9.1 20.0 5.6
MS-6 (1) 19.0 14.6 18.2 13.1
MS-7 (3) 52.4 58.5 50.0 50.0 84.6 58.9

H, number of haplotypes. Only haplotypes with prevalence ≥5% were included.

Significant differences in the annual prevalence of haplotypes are highlighted in bold (χ2 test): Pfmdr1 NYN between 2008 and 2010 (P = 0.0468), 2008 and 2012 (P = 0.0172) and between 2009 and 2012 (P = 0.0201); pfmdr1 NFN between 2008 and 2010 (P = 0.0468) and 2008 and 2012 (P = 0.0172); pfmrp1 HNSHITF between 2008 and 2010 (P = 0.0277), and pfnhe1 MS-7 between 2008 and 2012 (P = 0.0067) and between 2009 and 2012 (P = 0.0406).

a

Haplotypes were based on amino acids at the positions pfcrt (72, 74, 75, 76, 220); pfmdr1(86, 184,1042); pfdhfr(51, 59, 108, 164), pfdhps(436, 437, 540, 581); andpfmrp1(191, 325, 437, 785, 876, 1007, 1390). Mutant residues are in bold. For the pfnhe1 haplotypes, the number in parenthesis indicates the copy number of DNNND repeats.